Biventricular adaptation to volume overload in mice with aortic regurgitation

Journal of Cardiovascular Magnetic Resonance

Volumn 11, Issue 1, 2009, Pages

  Berry, Christopher J ^a   Miller, Jordan D ^b   McGroary, Kellyann ^a   Thedens, Daniel R ^a   Young, Stephen G ^c   Heistad, Donald D ^a   Weiss, Robert M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA VALVE REGURGITATION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HYPERCHOLESTEROLEMIA; HYPERVOLEMIA; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; SCREENING; ANIMAL; DISEASE MODEL; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITALIZATION; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY;

APOLIPOPROTEIN B100; CARRIER PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; AORTIC VALVE INSUFFICIENCY; APOLIPOPROTEIN B-100; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HYPERCHOLESTEROLEMIA; MAGNETIC RESONANCE IMAGING, CINE; MALE; MICE; MICE, MUTANT STRAINS; RECEPTORS, LDL; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR REMODELING;

EID: 70349562539     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-11-27     Document Type: Article

References (23)

1. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). JP Singh JC Evans D Levy MG Larson LA Freed DL Fuller B Lehman EJ Benjamin, Am J Cardiol 1999 83 897 902 10.1016/S0002-9149(98)01064-9 10190406
2. Contemporary approach to aortic and mitral regurgitation. JS Borer RO Bonow, Circulation 2003 108 2432 2438 10.1161/01.CIR.0000096400.00562.A3 14623790
3. Aortic Valve Replacement for the asymptomatic patient with aortic regurgitation: a new piece of the strategic puzzle. JS Borer, Circulation 2002 106 2637 2639 10.1161/01.CIR.0000040585.99021.8E 12438284
4. Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). WC Roberts JM Ko TR Moore WH Jones, Circulation 2006 114 422 429 10.1161/CIRCULATIONAHA.106. 622761 16864725
5. Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion. HD Lieu SK Withycombe Q Walker JX Rong RL Walzem JS Wong RL Hamilton EA Fisher SG Young, Circulation 2003 107 1315 1321 10.1161/01.CIR.0000054781. 50889.0C 12628954
6. Calcific aortic valve stenosis in old hypercholesterolemic mice. RM Weiss M Ohashi JD Miller SG Young DD Heistad, Circulation 2006 114 2065 2069 10.1161/CIRCULATIONAHA.106.634139 17075015
7. Normalization of hypercholesterolemia halts progression of aortic valve disease in mice. JD Miller RM Weiss KM Serrano RM Brooks CJ Berry K Zimmerman SG Young DD Heistad, Circulation 2009 119 2693 701 10.1161/CIRCULATIONAHA.108. 834614 19433756
8. Aortic valve calcification: basic science to clinical practice. K Akat M Borggrefe JJ Kaden, Heart 2009 95 616 623 10.1136/hrt.2007.134783 18632833
9. Effects of deep sedation or general anesthesia on cardiac function in mice undergoing cardiac magnetic resonance imaging. CJ Berry DR Thedens KA Light-McGroary JD Miller W Kutschke KA Zimmerman RM Weiss, J Cardiovasc Magnet Res 2009 19 16 10.1186/1532-429X-11-16
10. Evaluation of valvular heart disease with cine gradient echo magnetic resonance imaging. CB Higgins S Wagner C Kondo J Suzuki GR Caputo, Circulation 1991 84 Suppl I 198 207
11. Primer of Biostatistics Version 4.02 for Windows. SA Glantz, New York: McGraw Hill 1996
12. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. RV Freeman CM Otto, Circulation 2005 111 3316 3326 10.1161/CIRCULATIONAHA.104.486738 15967862
13. Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia. A Kawaguchi K Miyatake C Yutani S Beppu M Tsushima T Yamamura A Yamamoto, Amer H J 1999 137 410 418 10.1016/S0002-8703(99)70485-0
14. Longitudinal Evaluation and Assessment of Cardiovascular Disease in Patients With Homozygous Familial Hypercholesterolemia. DM Kolansky M Cuchel BJ Clark S Paridon BW McCrindle SE Siegers L Araujo Y Vohra JC Defesche JM Wilson DJ Rader, Am J Cardiol 2008 102 1438 1443 10.1016/j.amjcard.2008.07.035 19026292
15. ACC/AHA 2006 Guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. RO Bonow BA Carabello K Chatterjee AC de Leon Jr DP Faxon MD Freed WH Gaasch BW Lytle RA Nishimura PT O'Gara RA O'Rourke CM Otto PM Shah JS Shanewise, Circulation 2006 114 84 231e 10.1161/CIRCULATIONAHA.106.176857 16880336
16. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. R Scognamiglio SH Rahimtoola G Fasoli S Nistri S Dalla Volta, N Engl J Med 1994 331 1417 1423 10.1056/NEJM199409153311101
17. Long-term vasodilator therapy in patients with severe aortic regurgitation. A Evangelista P Tornos A Sambola G Permanyer-Miralda J Soler-Soler, N Engl J Med 2005 353 1342 1349 10.1056/NEJMoa050666 16192479
18. Right Ventricular Function and Failure: Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. NF Voelkel RA Quaife LA Leinwand RJ Barst MD McGoon DR Meldrum J Dupuis CS Long LJ Rubin FW Smart YJ Suzuki M Gladwin EM Denholm DB Gail, Circulation 2006 114 1883 1891 10.1161/CIRCULATIONAHA.106.632208 17060398
19. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. S Ghio A Gavazzi C Campana C Inserra C Klersy R Sebastiani E Arbustini F Recusani L Tavazzi, J Am Coll Cardiol 2001 37 183 188 10.1016/S0735-1097(00)01102-5 11153735
20. Right ventricular myocardial performance index predicts perioperative mortality and circulatory failure in high-risk valvular surgery. F Haddad AY Denault Couture R Cartier M Pellerin S Levesque J Lambert JC Tardif, J Am Soc Echocardiogr 2007 20 1065 1072 10.1016/j.echo.2007.02.017 17566702
21. Age-associated aortic stenosis in apolipoprotein E-deficient mice. K Tanaka M Sata D Fukuda Y Suematsu N Motomura S Takamoto Y Hirata R Nagai, J Am Coll Cardiol 2005 46 134 141 10.1016/j.jacc.2005.03.058 15992647
22. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. E Aikawa M Nahrendorf D Sosnovik VM Lok FA Jaffer M Aikawa R Weissleder, Circulation 2007 115 377 386 10.1161/CIRCULATIONAHA.106.654913 17224478
23. Cardiac manifestations in the mouse model of mucopolysaccharidosis I. MC Jordan Y Zheng S Ryazantsev N Rozengurt KP Roos EF Neufeld, Mol Genet Metab 2005 86 233 43 15979918 10.1016/j.ymgme.2005.05.003